SARA BOYSEN: Open Payments
NPI 1194273516 · EMMETSBURG, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 7 payments from 6 companies in 2025. Trend: 2023 $46 · 2024 $0 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $69 |
| Alkermes, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Viatris Specialty LLC | 1 | $15 |
| PFIZER INC. | 1 | $15 |
Products named: COBENFY, ARISTADA, CAMZYOS, UZEDY, GVOKE HYPOPEN, YUPELRI, ELIQUIS.
Industry payments across IA — which companies pay providers there.
